ASH1L and prostate neoplasm: Besides, we found that genetic amplification of ASH1L was associated with worse overall survival in men with metastatic PCa (Supplementary Fig. 1c), and human prostate tumors with high ASH1L mRNA levels exhibited an enriched cancer metastasis profile (Supplementary Fig. 1d).